MA48479A - Méthodes d'induction de la chondrogenèse - Google Patents
Méthodes d'induction de la chondrogenèseInfo
- Publication number
- MA48479A MA48479A MA048479A MA48479A MA48479A MA 48479 A MA48479 A MA 48479A MA 048479 A MA048479 A MA 048479A MA 48479 A MA48479 A MA 48479A MA 48479 A MA48479 A MA 48479A
- Authority
- MA
- Morocco
- Prior art keywords
- induction methods
- chondrogenesis induction
- chondrogenesis
- methods
- induction
- Prior art date
Links
- 230000022159 cartilage development Effects 0.000 title 1
- 230000006698 induction Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/452—Lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762489397P | 2017-04-24 | 2017-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA48479A true MA48479A (fr) | 2020-03-04 |
Family
ID=63919101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA048479A MA48479A (fr) | 2017-04-24 | 2018-04-23 | Méthodes d'induction de la chondrogenèse |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210361600A1 (fr) |
| EP (1) | EP3615021A4 (fr) |
| JP (2) | JP2020517597A (fr) |
| KR (1) | KR20190137904A (fr) |
| CN (1) | CN110809468A (fr) |
| AU (1) | AU2018257769A1 (fr) |
| CA (1) | CA3060518A1 (fr) |
| MA (1) | MA48479A (fr) |
| RU (1) | RU2019136884A (fr) |
| WO (1) | WO2018200411A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020168096A1 (fr) * | 2019-02-13 | 2020-08-20 | Yale University | Méthodes de traitement de l'épilepsie |
| FI129515B (en) | 2020-11-06 | 2022-03-31 | Salarusta Oy | FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9464065B2 (en) * | 2011-03-24 | 2016-10-11 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| KR102283996B1 (ko) * | 2013-03-15 | 2021-07-29 | 더 스크립스 리서치 인스티튜트 | 연골형성의 유도를 위한 화합물 및 방법 |
| EP3143026B1 (fr) * | 2014-05-13 | 2024-07-10 | Novartis AG | Composés et compositions d'induction de la chondrogenèse |
-
2018
- 2018-04-23 JP JP2019555835A patent/JP2020517597A/ja active Pending
- 2018-04-23 RU RU2019136884A patent/RU2019136884A/ru unknown
- 2018-04-23 WO PCT/US2018/028939 patent/WO2018200411A1/fr not_active Ceased
- 2018-04-23 US US16/606,672 patent/US20210361600A1/en not_active Abandoned
- 2018-04-23 MA MA048479A patent/MA48479A/fr unknown
- 2018-04-23 CN CN201880042328.6A patent/CN110809468A/zh active Pending
- 2018-04-23 AU AU2018257769A patent/AU2018257769A1/en not_active Abandoned
- 2018-04-23 CA CA3060518A patent/CA3060518A1/fr active Pending
- 2018-04-23 EP EP18791842.0A patent/EP3615021A4/fr not_active Withdrawn
- 2018-04-23 KR KR1020197034179A patent/KR20190137904A/ko not_active Ceased
-
2022
- 2022-12-07 JP JP2022195986A patent/JP2023071181A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN110809468A (zh) | 2020-02-18 |
| CA3060518A1 (fr) | 2018-11-01 |
| RU2019136884A3 (fr) | 2021-08-03 |
| RU2019136884A (ru) | 2021-05-25 |
| JP2020517597A (ja) | 2020-06-18 |
| EP3615021A4 (fr) | 2020-12-30 |
| EP3615021A1 (fr) | 2020-03-04 |
| WO2018200411A1 (fr) | 2018-11-01 |
| KR20190137904A (ko) | 2019-12-11 |
| AU2018257769A1 (en) | 2019-11-07 |
| JP2023071181A (ja) | 2023-05-22 |
| US20210361600A1 (en) | 2021-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3607587A4 (fr) | Panneau d'affichage | |
| EP3478842A4 (fr) | Composés et méthodes permettant de moduler la fonction de l'arn | |
| EP3492223A4 (fr) | Machine d'entraînement | |
| EP3308907A4 (fr) | Machine d'entraînement | |
| EP3464313A4 (fr) | Nucléotides modifiés 5 '-cyclo-phosphonate | |
| EP3324978A4 (fr) | Compositions d'oligonucléotides et méthodes associées | |
| EP3353328A4 (fr) | Modulateurs de l'expression de kras | |
| EP3364427A4 (fr) | Bobine d'induction de puissance | |
| FR3016945B1 (fr) | Plaque d'amortissement | |
| EP3663049A4 (fr) | Machine d'enfoncement | |
| MA71468A (fr) | Compositions et méthodes pour diminuer l'expression de tau | |
| EP3437540A4 (fr) | Support d'endoscope | |
| MA46717A (fr) | Variantes de l'endonucléase homing tcra | |
| EP3397288A4 (fr) | Méthodes pour diminuer l'expression de l'ataxine-2 | |
| EP3876936A4 (fr) | Méthodes de réduction des tumeurs pituitaires | |
| EP3506863A4 (fr) | Applicateurs d'implant | |
| MA51864A (fr) | Méthodes d'identification de composés | |
| IL268905B (en) | Phage therapy | |
| EP3525479A4 (fr) | Casque d'écoute | |
| EP3370708A4 (fr) | Modulation de l'expression de l'apolipoprotéine (a) | |
| EP3467761A4 (fr) | Serveur d'envoi de corbillard | |
| EP3496882A4 (fr) | Plaque d'amortissement | |
| BE1022355A1 (fr) | Nouvelles méthodes d'induction d'une réponse immunitaire | |
| EP3673085A4 (fr) | Méthodes de criblage d'enzyme | |
| EP3444345A4 (fr) | Dérivé d'arnmicro-143 |